Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Haytham O. Tawfik, Amany Belal, Mohammed A. S. Abourehab, Andrea Angeli, Alessandro Bonardi, Claudiu T. Supuran & Mervat H. El-Hamamsy. (2022) Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2765-2785.
Read now
Read now
Mohammed S. Taghour, Hazem A. Mahdy, Maher H. Gomaa, Ahmed Aglan, Mahmoud Gomaa Eldeib, Alaa Elwan, Mohammed A. Dahab, Eslam B. Elkaeed, Aisha A. Alsfouk, Mohamed M. Khalifa, Ibrahim H. Eissa & Hazem Elkady. (2022) Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2063-2077.
Read now
Read now
Mona F. Said, Riham F. George, Andrea Petreni, Claudiu T. Supuran & Nada M. Mohamed. (2022) Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors with antiproliferative activity. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 701-717.
Read now
Read now
Siddharth J. Modi & Vithal M. Kulkarni. (2022) Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors. Journal of Biomolecular Structure and Dynamics 40:12, pages 5712-5727.
Read now
Read now
Mohammed M. Alanazi, Ibrahim H. Eissa, Nawaf A. Alsaif, Ahmad J. Obaidullah, Wael A. Alanazi, Abdullah F. Alasmari, Hussam Albassam, Hazem Elkady & Alaa Elwan. (2021) Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1760-1782.
Read now
Read now
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Alaa Elwan & Hazem Elkady. (2021) Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1093-1114.
Read now
Read now
Yanyan Jia, Meijuan Li, Yuan Cao, Wenlong Feng, Xueru Li, Wenhua Xue & Huirong Shi. (2020) Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis Against Ovarian Cancer OVCAR-8 Cells. Drug Design, Development and Therapy 14, pages 207-216.
Read now
Read now
Mostafa M Ghorab, Ali S Alqahtani, Aiten M Soliman & Ahmed A Askar. (2020) Novel N-(Substituted) Thioacetamide Quinazolinone Benzenesulfonamides as Antimicrobial Agents. International Journal of Nanomedicine 15, pages 3161-3180.
Read now
Read now
Aiten M. Soliman, Ali S. Alqahtani & Mostafa M. Ghorab. (2019) Novel sulfonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 1030-1040.
Read now
Read now
Articles from other publishers (42)
Samir Bondock, Tallah Albarqi, Moaz M. Abdou & Nada M. Mohamed. (2023) Computational insights into novel benzenesulfonamide-1,3,4-thiadiazole hybrids as a possible VEGFR-2 inhibitor: design, synthesis and anticancer evaluation with molecular dynamics studies. New Journal of Chemistry 47:44, pages 20602-20618.
Crossref
Crossref
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, Samineh Massah & Ahmad Reza Massah. (2023) Recent Advances in Biological Active Sulfonamide based Hybrid
Compounds Part C: Multicomponent Sulfonamide Hybrids. Current Medicinal Chemistry 30:37, pages 4181-4255.
Crossref
Crossref
Mahfam Moradi, Alireza Mousavi, Zahra Emamgholipour, Johanna Giovannini, Setareh Moghimi, Fariba Peytam, Amin Honarmand, Stéphane Bach & Alireza Foroumadi. (2023) Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies. European Journal of Medicinal Chemistry 259, pages 115626.
Crossref
Crossref
Mostafa M. Ghorab, Aiten M. Soliman, Khaled El-Adl & Noura S. Hanafy. (2023) New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity. Bioorganic Chemistry 140, pages 106791.
Crossref
Crossref
Kavita Singh, Sunil Sharma, Rajdeep Tyagi & Ram Sagar. (2023) Recent progress in the synthesis of natural product inspired bioactive glycohybrids. Carbohydrate Research, pages 108975.
Crossref
Crossref
Aiten M. Soliman, Walid M. Ghorab, Dina M. Lotfy, Heba M. Karam, Mostafa M. Ghorab & Laila A. Ramadan. (2023) Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors. Scientific Reports 13:1.
Crossref
Crossref
Zanele F Dube, Opeyemi S Soremekun, Thandokuhle Ntombela, Mohammed Issa Alahmdi, Nader E Abo-Dya, Peter A Sidhom, Ahmed M Shawky, Mohamed F Shibl, Mahmoud AA Ibrahim & Mahmoud ES Soliman. (2023)
Inherent efficacies of pyrazole-based derivatives for cancer therapy: the interface between experiment and
in silico
. Future Medicinal Chemistry 15:18, pages 1719-1738.
Crossref
Crossref
Mostafa GM El-Gazzar, Marwa G El-Gazzar & Mostafa M Ghorab. (2023) Quinazolinone derivatives as new potential CDK4/6 inhibitors, apoptosis inducers and radiosensitizers for breast cancer. Future Medicinal Chemistry.
Crossref
Crossref
Sagiru Hamza Abdullahi, Adamu Uzairu, Ammar Usman Danazumi, Elizabeth Finbarrs-Bello, Abdullahi Bello Umar, Gideon Adamu Shallangwa & Sani Uba. (2023) Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies. Biocatalysis and Agricultural Biotechnology 51, pages 102787.
Crossref
Crossref
Zeinab S. El-Fakharany, Yassin M. Nissan, Nada K. Sedky, Reem K. Arafa & Sahar M. Abou-Seri. (2023) New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition. Scientific Reports 13:1.
Crossref
Crossref
Atamjit Singh, Karanvir Singh, Aman Sharma, Sambhav Sharma, Kevin Batra, Kaustubh Joshi, Brahmjeet Singh, Kirandeep Kaur, Renu Chadha & Preet Mohinder Singh Bedi. (2023) Mechanistic insight and structure activity relationship of isatin-based derivatives in development of anti-breast cancer agents. Molecular and Cellular Biochemistry.
Crossref
Crossref
Nader R. Albujuq, Khalid Althumayri, Reem A. K Alharbi, Ahmed A. Al‐Karmalawy & Mohamed S. Nafie. (2023)
Design and Synthesis of Benzenesulfonamides Coupled with Piperidine, Morpholine, and
N
,
N
‐Dimethylethanamine Moieties as Apoptotic Inducers through VEGFR2 and Topoisomerase II Inhibition
. ChemistrySelect 8:20.
Crossref
Crossref
Mostafa M. Ghorab, Aiten M. Soliman, Gharieb S. El-Sayyad, Maged S. Abdel-Kader & Ahmed I. El-Batal. (2023) Synthesis, Antimicrobial, and Antibiofilm Activities of Some Novel 7-Methoxyquinoline Derivatives Bearing Sulfonamide Moiety against Urinary Tract Infection-Causing Pathogenic Microbes. International Journal of Molecular Sciences 24:10, pages 8933.
Crossref
Crossref
Xiu-Juan Liu, Hong-Cheng Zhao, Su-Juan Hou, Hao-Jie Zhang, Lei Cheng, Shuo Yuan, Li-Rong Zhang, Jian Song, Sai-Yang Zhang & Shi-Wu Chen. (2023) Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy. Bioorganic Chemistry 133, pages 106425.
Crossref
Crossref
Mostafa M Ghorab, Ali S Alqahtani, Aiten M Soliman & Ahmed A Askar. (2023) Antimicrobial, anticancer and immunomodulatory potential of new quinazolines bearing benzenesulfonamide moiety. Future Medicinal Chemistry 15:3, pages 275-290.
Crossref
Crossref
Sally S. Zahran, Fatma A. Ragab, Marwa G. El-Gazzar, Aiten M. Soliman, Walaa R. Mahmoud & Mostafa M. Ghorab. (2023) Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4(3H)-ones and sulfachloropyridazine. European Journal of Medicinal Chemistry 245, pages 114912.
Crossref
Crossref
Nurul Ajilah Mohamed Khir, Ain’ Sabreena Mohd Noh, Idris Long, Norjihada Izzah Ismail, Rosfaiizah Siran & Che Aishah Nazariah Ismail. (2022) Inflammatory-associated apoptotic markers: are they the culprit to rheumatoid arthritis pain?. Molecular Biology Reports 49:10, pages 10077-10090.
Crossref
Crossref
Manar G. Salem, Dina M. Abu El-Maaty, Yassmina I. Mohey El-Deen, Basem H. Elesawy, Ahmad El Askary, Asmaa Saleh, Essa M. Saied & Mohammed El Behery. (2022) Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study. Molecules 27:15, pages 4898.
Crossref
Crossref
Bessy Mary Philip, Jerin Susan John, Shyni V, Tintu K Kuruvilla, Tressia Alias Princy Paulose & D. Sajan. (2022) Vibrational spectra and molecular docking studies of bergapten isolated from Melicopedenhamii leaves as anti-breast cancer agents. Journal of Molecular Structure 1258, pages 132656.
Crossref
Crossref
Mohamed S. Nafie & Ahmed T.A. Boraei. (2022) Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer. Bioorganic Chemistry 122, pages 105708.
Crossref
Crossref
Ali S. Alqahtani, Mostafa M. Ghorab, Fahd A. Nasr, Mohammad Z. Ahmed, Abdullah A. Al-Mishari & Sabry M. Attia. (2022) The Antiproliferative and Apoptotic Effects of a Novel Quinazoline Carrying Substituted-Sulfonamides: In Vitro and Molecular Docking Study. Molecules 27:3, pages 981.
Crossref
Crossref
Carolina Ortiz-Cordero, Claudia Bincoletto, Neha R. Dhoke, Sridhar Selvaraj, Alessandro Magli, Haowen Zhou, Do-Hyung Kim, Anne G. Bang & Rita C.R. Perlingeiro. (2021) Defective autophagy and increased apoptosis contribute toward the pathogenesis of FKRP-associated muscular dystrophies. Stem Cell Reports 16:11, pages 2752-2767.
Crossref
Crossref
Mohammed M. Alanazi, Hazem Elkady, Nawaf A. Alsaif, Ahmad J. Obaidullah, Hamad M. Alkahtani, Manal M. Alanazi, Madhawi A. Alharbi, Ibrahim H. Eissa & Mohammed A. Dahab. (2021)
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with
in silico
docking, ADMET, toxicity, and DFT studies
. RSC Advances 11:48, pages 30315-30328.
Crossref
Crossref
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, Alan P. Kumar, Jimmy Stalin, Curzio Ruegg & Ramaa C S. (2021) Recent Anti‐angiogenic Drug Discovery Efforts To Combat Cancer. ChemistrySelect 6:23, pages 5689-5700.
Crossref
Crossref
Aiten M. Soliman, Mai H. Mekkawy, Heba M. Karam, Maureen Higgins, Albena T. Dinkova-Kostova & Mostafa M. Ghorab. (2021) Novel iodinated quinazolinones bearing sulfonamide as new scaffold targeting radiation induced oxidative stress. Bioorganic & Medicinal Chemistry Letters 42, pages 128002.
Crossref
Crossref
Marwa F. Ahmed & Eman Y. Santali. (2021) Discovery of pyridine- sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers. Bioorganic Chemistry 111, pages 104842.
Crossref
Crossref
Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Hazem A. Mahdy & Hazem Elkady. (2021) New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorganic Chemistry 110, pages 104807.
Crossref
Crossref
Bin Zhang, Zhikun Liu, Shengjin Xia, Qingqing Liu & Shaohua Gou. (2021) Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors. European Journal of Medicinal Chemistry 216, pages 113300.
Crossref
Crossref
Mostafa M. Ghorab, Aiten M. Soliman, Silvia Bua & Claudiu T. Supuran. (2021) Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors. Bioorganic Chemistry 107, pages 104618.
Crossref
Crossref
Deepika Sharma, Naveen Kumar, Tarang Mehrotra, Naveed Pervaiz, Lokesh Agrawal, Shalini Tripathi, Abhishek Jha, Thanasis Poullikkas, Ravinder Kumar & Lalita Ledwani. (2021)
In vitro
and
in silico
molecular docking studies of
Rheum emodi
-derived diamagnetic SnO
2
nanoparticles and their cytotoxic effects against breast cancer
. New Journal of Chemistry 45:3, pages 1695-1711.
Crossref
Crossref
Hatem A. Abuelizz, Mohamed Marzouk, Ahmed H. Bakheit, Hanem M. Awad, Maha M. Soltan, Ahmed M. Naglah & Rashad Al-Salahi. (2020) Antiproliferative and Antiangiogenic Properties of New VEGFR-2-targeting 2-thioxobenzo[g]quinazoline Derivatives (In Vitro). Molecules 25:24, pages 5944.
Crossref
Crossref
Mohamed G. Thabit, Amany S. Mostafa, Khalid B. Selim, Magda A.A. Elsayed & Magda N.A. Nasr. (2020) Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity. Bioorganic Chemistry 103, pages 104148.
Crossref
Crossref
Aiten M. Soliman, Mostafa M. Ghorab, Silvia Bua & Claudiu T. Supuran. (2020) Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity. European Journal of Medicinal Chemistry 200, pages 112449.
Crossref
Crossref
Aiten M. Soliman, Heba M. Karam, Mai H. Mekkawy & Mostafa M. Ghorab. (2020) Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway. European Journal of Medicinal Chemistry 197, pages 112333.
Crossref
Crossref
Eman Y. Ahmed, Nehad A. Abdel Latif, Mohamed F. El-Mansy, Weam S. Elserwy & Omaima M. Abdelhafez. (2020) VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents. Bioorganic & Medicinal Chemistry 28:5, pages 115328.
Crossref
Crossref
Marwa G. El-Gazzar, Rania M. El-Hazek, Nashwa H. Zaher & Mona A. El-Ghazaly. (2019) Design and synthesis of novel pyridazinoquinazoline derivatives as potent VEGFR-2 inhibitors: In vitro and in vivo study. Bioorganic Chemistry 92, pages 103251.
Crossref
Crossref
Aiten M. Soliman & Mostafa M. Ghorab. (2019) Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents. Bioorganic Chemistry 88, pages 102956.
Crossref
Crossref
Siddharth J. Modi & Vithal M. Kulkarni. (2019) Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective. Medicine in Drug Discovery 2, pages 100009.
Crossref
Crossref
Shailima Rampogu, Ayoung Baek, Chanin Park, Shraddha Parate, Saravanan Parameswaran, Yohan Park, Baji Shaik, Ju Hyun Kim, Seok Ju Park & Keun Woo Lee. (2019) Discovery of Small Molecules that Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies. Cells 8:3, pages 269.
Crossref
Crossref
Mostafa M. Ghorab, Mansour S. Alsaid & Aiten M. Soliman. (2018) Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers. Bioorganic Chemistry 80, pages 611-620.
Crossref
Crossref
Chih-Ling Chung, Shih-Wei Wang, Wei-Chih Sun, Chih-Wen Shu, Yu-Chen Kao, Meng-Shin Shiao & Chun-Lin Chen. (2018) Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma. Biochemical Pharmacology 154, pages 39-53.
Crossref
Crossref
Mansour S. Alsaid, Abdullah A. Al-Mishari, Aiten M. Soliman, Fatma A. Ragab & Mostafa M. Ghorab. (2017) Discovery of Benzo[g]quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. European Journal of Medicinal Chemistry 141, pages 84-91.
Crossref
Crossref